IL-6 is thought to evoke immune responses typical of both T2 and non-T2 inflammation as evidenced by increased serum eosinophilia and fraction of exhaled nitric oxide, as well as Th17-mediated neutrophilia in patients with high IL-6 and asthma [29, 30]. This evidence concerns the gene IL6 and asthma.